[Consumption analyze of the antihypertensive drugs in Morocco: period 1991-2005].
BACKGROUND
The medical assumption of responsibility of the chronic diseases in Morocco, in particular arterial hypertension, remains problematic.


OBJECTIVE
To evaluate the consumption, segmentation and the share of the market of generic antihypertensive drugs during the period: 1991-2005.


METHODS
The data were elaborate starting from the declarations of IMS health (Intercontinental Marketing Service) for Morocco. These data related to the sales with only the pharmacies and were expressed as daily defined dose (DDD)/1000 inhabitant-days.


RESULTS
The consumption of the antihypertensive drugs increased from 2 to 10 DDD/1000 between 1991 and 2005. The family of diuretics drugs was the most consumed (3.5 DDD/1000) followed by nonassociated beta-blockers (2 DDD/1000) in 2005. The segmentation was primarily represented by the diuretics (34%) and the beta-blockers (20%). The market of generic antihypertensive drugs passed from 3.3% in 1991 to 21.7% in 2005.


CONCLUSIONS
The consumption of the antihypertensive drugs in Morocco remains too low in spite of an increasing tendency to depend especially on the generic drugs.
Département de Pharmaco-Toxicologie, Faculté de Médecine et de Pharmacie, Rabat, Maroc. drisssoussitanani@hotmail.com
Driss
D
Soussi-Tanani
Katim
K
Alaoui
Abdelmajid
A
Belaiche
Mohammed
M
Hassar
Yahia
Y
Cherrah
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004363:Drug Utilization; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology; D009018:Morocco / Q000453:epidemiology; D010594:Pharmacies
D000959:Antihypertensive Agents